Michael J. Sundborg

588 total citations
19 papers, 433 citations indexed

About

Michael J. Sundborg is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Michael J. Sundborg has authored 19 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Obstetrics and Gynecology, 11 papers in Reproductive Medicine and 6 papers in Oncology. Recurrent topics in Michael J. Sundborg's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Uterine Myomas and Treatments (4 papers). Michael J. Sundborg is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Uterine Myomas and Treatments (4 papers). Michael J. Sundborg collaborates with scholars based in United States, Spain and Japan. Michael J. Sundborg's co-authors include William E. Winter, G. Scott Rose, Peter G. Rose, Chunqiao Tian, G. Larry Maxwell, William P. McGuire, Stephen C. Rubin, Franco M. Muggia, Charles A. Leath and William J. Lowery and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Annals of Oncology.

In The Last Decade

Michael J. Sundborg

16 papers receiving 422 citations

Peers

Michael J. Sundborg
David Starks United States
Mihai Meirovitz Israel
Jose L. Mira United States
Mahalakshmi Gurumurthy United Kingdom
Gary L. Eddy United States
A.J. Kruse Netherlands
Yorito Yamamoto Japan
Chailert Phongnarisorn Thailand
Sunesh Kumar Jain India
Charuwan Tantipalakorn Thailand
David Starks United States
Michael J. Sundborg
Citations per year, relative to Michael J. Sundborg Michael J. Sundborg (= 1×) peers David Starks

Countries citing papers authored by Michael J. Sundborg

Since Specialization
Citations

This map shows the geographic impact of Michael J. Sundborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Sundborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Sundborg more than expected).

Fields of papers citing papers by Michael J. Sundborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Sundborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Sundborg. The network helps show where Michael J. Sundborg may publish in the future.

Co-authorship network of co-authors of Michael J. Sundborg

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Sundborg. A scholar is included among the top collaborators of Michael J. Sundborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Sundborg. Michael J. Sundborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Secord, Angeles Alvarez, Michael J. Sundborg, Destin Black, et al.. (2025). A phase 3, open-label, randomized study of rinatabart sesutecan (Rina-S) vs investigator’s choice (IC) of chemotherapy in patients with platinum-resistant ovarian cancer (PROC).. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
2.
3.
4.
5.
6.
Nieuwenhuysen, Els Van, Jean‐François Baurain, Hye Sook Chon, et al.. (2024). Durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer (EC) in DUO-E: Results by BRCA1/BRCA2 mutation (BRCAm) status.. Journal of Clinical Oncology. 42(16_suppl). 5595–5595. 2 indexed citations
7.
Chon, Hye Sook, Michael J. Sundborg, Michael A. Gold, et al.. (2024). Safety and tolerability of durvalumab + carboplatin/paclitaxel followed by durvalumab ± olaparib in patients with newly diagnosed advanced or recurrent endometrial cancer (EC) in the DUO-E/GOG-3041/ENGOT-EN10 trial.. Journal of Clinical Oncology. 42(16_suppl). 5599–5599. 1 indexed citations
8.
9.
Reed, Beverly G, William J. Lowery, Edward R. Kost, et al.. (2011). Surgically managed stage I endometrial cancer in a low-volume center: outcomes and complications in a military residency program. American Journal of Obstetrics and Gynecology. 205(4). 356.e1–356.e5. 2 indexed citations
10.
Leath, Charles A., et al.. (2011). Reaction to a Surgical Implant Foreign Body Masquerading as Recurrent Uterine Sarcoma. Obstetrics and Gynecology. 117(2). 450–452. 5 indexed citations
11.
Sundborg, Michael J., et al.. (2010). Undifferentiated Uterine Sarcoma Presenting as a Pathologic Humerus Fracture. Military Medicine. 175(9). 691–692. 1 indexed citations
12.
Reed, Beverly G, William J. Lowery, Michael J. Sundborg, et al.. (2010). Hospice enrollment for terminally ill patients with gynecologic malignancies: Impact on outcomes and interventions. Gynecologic Oncology. 118(3). 274–277. 29 indexed citations
13.
Lowery, William J., et al.. (2009). Cervical Signet-Ring Cell Carcinoma Presenting as a Synchronous Primary Carcinoma with Uterine Adenocarcinoma. Military Medicine. 174(2). 212–213. 4 indexed citations
14.
Sundborg, Michael J., et al.. (2009). Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC‐H. Diagnostic Cytopathology. 38(5). 313–317. 19 indexed citations
15.
Winter, William E., G. Larry Maxwell, Chunqiao Tian, et al.. (2007). Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 26(1). 83–89. 293 indexed citations
16.
Krivak, Thomas C., et al.. (2004). The utility of hand-assisted laparoscopy in ovarian cancer. Gynecologic Oncology. 96(1). 72–76. 35 indexed citations
17.
Ellis, Michael W., et al.. (2004). Coccidioidomycosis Mimicking Ovarian Cancer. Obstetrics and Gynecology. 104(5). 1177–1179. 17 indexed citations
18.
Krivak, Thomas C., et al.. (2000). Cervical adenocarcinoma‐in‐situ: A meta‐analysis of therapeutic options and predictors of persistent or recurrent disease. International Journal of Gynecology & Obstetrics. 70(S2).
19.
Sundborg, Michael J.. (1998). Cystoscopy after computed tomography scan to identify bladder invasion in cervical cancer. Obstetrics and Gynecology. 92(3). 364–366. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Starks Breakdown of academic impact, for papers by Mihai Meirovitz Breakdown of academic impact, for papers by Jose L. Mira Breakdown of academic impact, for papers by Mahalakshmi Gurumurthy Breakdown of academic impact, for papers by Gary L. Eddy Breakdown of academic impact, for papers by A.J. Kruse Breakdown of academic impact, for papers by Yorito Yamamoto Breakdown of academic impact, for papers by Chailert Phongnarisorn Breakdown of academic impact, for papers by Sunesh Kumar Jain Breakdown of academic impact, for papers by Charuwan Tantipalakorn
Rankless by CCL
2026